Latest News
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
AZZ INC (NYSE:AZZ): A Peter Lynch GARP Play with Sustainable Growth and Reasonable Valuationchartmill.com
Via Chartmill · May 14, 2026
As crypto prices show signs of recovery, Solana, Chainlink, and Cardano all have long-term potential.
Via The Motley Fool · May 14, 2026
Via Talk Markets · May 14, 2026
Green Thumb just claimed a first-mover advantage in the changing U.S. cannabis landscape.
Via The Motley Fool · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
Boston Scientific Corp (NYSE:BSX) Shines in Quality "Caviar Cruise" Screenchartmill.com
Via Chartmill · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
Eli Lilly is dominating one of the biggest growth markets in healthcare: the weight loss drug market.
Via The Motley Fool · May 14, 2026
Germany is rearming rapidly, Rheinmetall is the best way to play it.
Via The Motley Fool · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
Trane Technologies (NYSE:TT) Passes the Caviar Cruise Quality Investing Screenchartmill.com
Via Chartmill · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
It's simpler than you might think to build wealth in the stock market.
Via The Motley Fool · May 14, 2026
Teva's turnaround is real -- and may not be over.
Via The Motley Fool · May 14, 2026
There's more than one way to maximize the amount of Social Security you receive in retirement.
Via The Motley Fool · May 14, 2026
Via Talk Markets · May 14, 2026
Via Talk Markets · May 14, 2026
Lazard Inc (NYSE:LAZ): A Decent Value Play with Growth Catalystchartmill.com
Via Chartmill · May 14, 2026
Arrowhead Pharmaceuticals (NASDAQ:ARWR) is moving into a more commercial phase while continuing to expand its RNA interference pipeline, Chief Executive Officer Chris Anzalone said during a presentation with BofA pharma and biotech analyst Jason Gerberry at the BofA Annual Healthcare Conference.
An
Via MarketBeat · May 14, 2026
PPL (NYSE:PPL) reported higher first-quarter earnings and reaffirmed its 2026 and long-term financial targets, while executives highlighted regulatory developments, data center-driven load growth and potential generation investments across the company’s service territories.
President and CEO Vince
Via MarketBeat · May 14, 2026
Permian Resources (NYSE:PR) reported what executives described as a record quarter for free cash flow and operational efficiency, while emphasizing that the company is preserving flexibility amid volatile commodity markets.
On the company’s first-quarter 2026 earnings call, Co-CEO Will Hickey said
Via MarketBeat · May 14, 2026
Primerica (NYSE:PRI) reported higher first-quarter 2026 adjusted operating revenue and earnings, driven by strong growth in its Investment and Savings Products business and stable performance in Term Life, executives said on the company’s earnings call.
Chief Executive Officer Glenn Williams said t
Via MarketBeat · May 14, 2026
Via Talk Markets · May 14, 2026
FAIR ISAAC CORP (NYSE:FICO) Shines in Quality Investing Screen with Stellar Profitability and Growthchartmill.com
Via Chartmill · May 14, 2026
Via Talk Markets · May 14, 2026
PennantPark Floating Rate Capital (NYSE:PFLT) reported flat net asset value and continued low non-accruals for its second fiscal quarter of 2026, while management said it is resetting the company’s dividend framework to better align payouts with current net investment income.
Chairman and Chief Exe
Via MarketBeat · May 14, 2026
Planet Fitness (NYSE:PLNT) reported stronger-than-expected first-quarter revenue and profit, but management said member growth fell short of expectations and outlined a reset of its marketing and pricing strategy aimed at reigniting joins among fitness beginners and casual gym users.
Chief Executiv
Via MarketBeat · May 14, 2026
Post (NYSE:POST) Holdings executives said the company’s diversified portfolio delivered second-quarter adjusted EBITDA above expectations, but management maintained its prior full-year adjusted EBITDA guidance because of new cost pressures tied to the conflict in the Middle East.
Daniel O’Rourke, P
Via MarketBeat · May 14, 2026
Future (LON:FUTR) reported a decline in first-half revenue and profit as changes in the search ecosystem weighed on programmatic advertising and e-commerce, but management said growth initiatives launched seven months ago are beginning to offset pressure in parts of the business.
Opening the earnin
Via MarketBeat · May 14, 2026
Accelerating inflation has made interest rate increases more likely, and they have historically been bad news for the stock market.
Via The Motley Fool · May 14, 2026
This top Wall Street firm is convinced about UnitedHealth's prospects. Is it right?
Via The Motley Fool · May 14, 2026